HLA dependent immune escape mechanisms in B-cell lymphomas: Implications for immune checkpoint inhibitor therapy?-Reference-Cited by-同舟云学术

HLA dependent immune escape mechanisms in B-cell lymphomas: Implications for immune checkpoint inhibitor therapy?

Published:2017-03-03 Issue:4 Volume:6 Page:e1295202
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Nijland Marcel¹,Veenstra Rianne N.²,Visser Lydia²,Xu Chuanhui²,Kushekhar Kushi²,van Imhoff Gustaaf W.¹,Kluin Philip M.²,van den Berg Anke²,Diepstra Arjan²

Affiliation:

1. Department of Hematology, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands

2. Department of Pathology and Medical Biology, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://tandfonline.com/doi/pdf/10.1080/2162402X.2017.1295202

Reference47 articles.

1. Breathing new life into immunotherapy: review of melanoma, lung and kidney cancer

2. The future of cancer treatment: immunomodulation, CARs and combination immunotherapy

3. Novel immunotherapies in lymphoid malignancies

4. Phase I Study of Ipilimumab, an Anti–CTLA-4 Monoclonal Antibody, in Patients with Relapsed and Refractory B-Cell Non–Hodgkin Lymphoma

5. PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune Characteristics and Immunotherapy of HIV-Associated Lymphoma;Current Issues in Molecular Biology;2024-09-10

2. Intra‐tumoral and peripheral blood TIGIT and PD‐1 as immune biomarkers in nodular lymphocyte predominant Hodgkin lymphoma;American Journal of Hematology;2024-08-17

3. Human leukocyte antigen (HLA) class I expression on Hodgkin–Reed–Sternberg cells is an EBV‐independent major determinant of microenvironment composition in classic Hodgkin lymphoma;HemaSphere;2024-06

4. Targeting the tumor microenvironment in primary central nervous system lymphoma: Implications for prognosis;Journal of Clinical Neuroscience;2024-06

5. HLA-DM and HLA-DO interplay for the peptide editing of HLA class II in healthy tissues and leukemia;Best Practice & Research Clinical Haematology;2024-06